Perceptions of health risks associated with pregnancy compared to oral contraceptive use

被引:4
|
作者
Nelson, Anita L. [1 ,2 ]
Shabaik, Salma [3 ]
Xandre, Pamela [4 ]
Kakaiya, Roshni [5 ]
Awaida, Joseph [6 ]
Mellon, Michelle [7 ]
Schiller, Andrew [8 ]
Stohl, Hindi E. [9 ]
机构
[1] Harbor UCLA Med Ctr, Los Angeles BioMed Res Inst, Torrance, CA 90509 USA
[2] Western Univ Hlth Sci, Pomona, CA 91766 USA
[3] Charles R Drew Univ Med & Sci, 1621 E 120th St, Los Angeles, CA 90059 USA
[4] Calif State Univ Long Beach, Sch Nursing, Long Beach, CA 90840 USA
[5] Tours Univ Calif, Vallejo, CA USA
[6] Calif State Univ Long Beach, Long Beach, CA 90840 USA
[7] Western Univ Hlth Sci, Coll Osteopath Med Northwest, Lebanon, OR USA
[8] Western Univ Hlth Sci, Coll Osteopath Med, Pomona, CA USA
[9] UCLA, David Geffen Sch Med, Harbor UCLA Med Ctr, Los Angeles, CA 90095 USA
关键词
Reproductive health literacy; Oral contraceptive health risks; Pregnancy health risks; Shared decision making; Oral contraceptive safety;
D O I
10.1016/j.contraception.2019.04.008
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To assess beliefs about the safety of oral contraceptives compared to pregnancy to determine if men and women possess accurate information to make informed choices. Study design: In each of six surveys conducted in Southern California from 2008 to 2017, participants were asked "Which do you think is more hazardous to a woman's health - birth control pills or pregnancy?" Results: A total of 28.4% of all 1839 male and female respondents and 29.1% of the 1712 female respondents answered correctly that the health risks posed by pregnancy were greater. In subgroup analyses, 64.4%-81.9% rated oral contraceptives at least as hazardous to a woman's health as pregnancy. Conclusion: The vast majority of respondents incorrectly believed that oral contraceptives are more hazardous than pregnancy. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:193 / 195
页数:3
相关论文
共 50 条
  • [31] Ischemic colitis associated with naratriptan and oral contraceptive use
    Charles, JA
    Pullicino, PM
    Stoopack, PM
    Shroff, Y
    [J]. HEADACHE, 2005, 45 (04): : 386 - 389
  • [32] Papillophlebitis associated with the use of oral contraceptive: a case report
    Yucel, Ozlem Eski
    Gungor, Inci
    Gul, Adem
    Turgut, Mehmet
    Ariturk, Nursen
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (08) : 601 - 603
  • [33] RISKS ASSOCIATED WITH COCAINE USE DURING PREGNANCY
    SLUTSKER, L
    [J]. OBSTETRICS AND GYNECOLOGY, 1992, 79 (05): : 778 - 789
  • [34] Epigenetic changes associated with Combined Oral Contraceptive Use
    Ellis, Laura
    Noshin, Promi
    Bowden, Sarah
    Flanagan, James
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 : 44 - 45
  • [35] THE NON-CONTRACEPTIVE HEALTH BENEFITS FROM ORAL-CONTRACEPTIVE USE
    ORY, HW
    [J]. FAMILY PLANNING PERSPECTIVES, 1982, 14 (04): : 182 - 184
  • [36] The risks associated with the use of lamotrigine during pregnancy
    Kong, Lingli
    Zhou, Tiantian
    Wang, Bailing
    Gao, Zhenbo
    Wang, Chunxia
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2018, 22 (01) : 2 - 5
  • [37] Women's Knowledge, Beliefs, and Information Needs in Relation to the Risks and Benefits Associated with Use of the Oral Contraceptive Pill
    Philipson, Sarah
    Wakefield, Claire E.
    Kasparian, Nadine A.
    [J]. JOURNAL OF WOMENS HEALTH, 2011, 20 (04) : 635 - 642
  • [38] Risks and benefits of oral contraceptive pills
    D'Souza, RE
    Guillebaud, J
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2002, 16 (02) : 133 - 154
  • [39] CHANGES IN THYROID-FUNCTION IN PREGNANCY AND WITH ORAL-CONTRACEPTIVE USE
    SOUMA, JA
    GREEN, PJ
    COPPAGE, AT
    DONNER, RS
    HOGG, AL
    [J]. SOUTHERN MEDICAL JOURNAL, 1981, 74 (06) : 684 - 687
  • [40] CLINICAL-CHEMISTRY ALTERATIONS IN PREGNANCY AND ORAL-CONTRACEPTIVE USE
    KNOPP, RH
    BERGELIN, RO
    WAHL, PW
    WALDEN, CE
    CHAPMAN, MB
    [J]. OBSTETRICS AND GYNECOLOGY, 1985, 66 (05): : 682 - 690